Skip to main content
Premium Trial:

Request an Annual Quote

Atlas Biolabs Named Roche NimbleGen CSP

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Roche NimgleGen today said that it has named Berlin, Germany-based Atlas Biolabs a certified service provider for the firm's SeqCap EZ enrichment product portfolio.

Atlas, which passed a certification process to qualify, will process customer gDNA samples for genomic enrichment using the complete NimbleGen Sequence Capture Array and solution-based capture workflow. The enriched samples can be analyzed afterward on the Roche GS FLX and GS Junior sequencing platforms, as well as on short-read sequencing platforms, said Roche.

Roche noted that its NimbleGen business recently launched a new addition to the SeqCap EZ product portfolio with SeqCap EZ Choice Libraries for enrichment of custom regions of interest in a single test tube.

Last September, Roche had announced that Aliso Viejo, Calif.-based Ambry Genetics was named a certified service provider for the Roche NimbleGen SeqCap EZ Exome workflow.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more